Back to Trades
Total Value
$20.3K
Net $20.3K bought
Filing Date
Jun 22, 2026
1 transaction
Purchases
$20.3K
1 transaction
Trade Summary
On Jun 17, 2026, Teleman Dan Benjamin, Chief Executive Officer, Director, purchased $20.3K of Nasus Pharma Ltd (NSRX) across 1 transaction. The filing covers Ordinary Shares and reflects net buying of $20.3K. Reported prices ranged from $3.10. Insider transactions are sourced from SEC Form 4 disclosures and should be reviewed alongside company fundamentals and the insider's broader trading history.
Company Information
- Company Name
- Nasus Pharma Ltd
- Ticker Symbol
- NSRX
- CIK
- 0002029039
Insider Information
- Role
- Chief Executive Officer, Director
Filing Details
- Filing Date
- Jun 22, 2026
- Transaction Date
- Jun 17, 2026
- Accession Number
- 0001493152-26-029484
- Form Type
- 4
- Net Trading Amount
- $20.3K
Non-Derivative Transactions
| Date | Security | Shares | Price | Type | Value |
|---|---|---|---|---|---|
| Jun 17, 2026 | Ordinary Shares | 6,550 | $3.10 | Purchase | $20.3K |
Want live alerts when Teleman Dan Benjamin trades again?
Download Insider Trades to track NSRX, follow insiders, and get mobile alerts when new SEC Form 4 filings are published.
Footnotes
- (F1)Consists of: (i) 30,696 ordinary shares, no par value per share ("Ordinary Shares"), and (ii) 132,845 Ordinary Shares issuable upon exercise of outstanding share options that are exercisable within 60 days.